| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 1555-1561, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
HC Anderson, HH Hsu, DC Morris, KN Fedde and MP Whyte
Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City 66160, USA.
Hypophosphatasia, a heritable disease characterized by deficient activity of the tissue nonspecific isoenzyme of alkaline phosphatase (TNSALP), results in rickets and osteomalacia. Although identification of TNSALP gene defects in hypophosphatasia establishes a role of ALP in skeletal mineralization, the precise function remains unclear. The initial site of mineralization (primary mineralization) normally occurs within the lumen of TNSALP-rich matrix vesicles (MVs) of growth cartilage, bone, and dentin. We investigated whether defective calcification in hypophosphatasia is due to a paucity and/or a functional failure of MVs secondary to TNSALP deficiency. Nondecalcified autopsy bone and growth plate cartilage from five patients with perinatal (lethal) hypophosphatasia were studied by nondecalcified light and electron microscopy to assess MV numbers, size, shape, and ultrastructure and whether hypophosphatasia MVs contain apatite-like mineral, as would be the case if these MVs retained their ability to concentrate calcium and phosphate internally despite a paucity of TNSALP in their investing membranes. We found that hypophosphatasia MVs are present in approximately normal numbers and distribution and that they are capable of initiating internal mineralization. There is retarded extravesicular crystal propagation. Thus, in hypophosphatasia the failure of bones to calcify appears to involve a block of the vectorial spread of mineral from initial nuclei within MVs, outwards, into the matrix. We conclude that hypophosphatasia MVs can concentrate calcium and phosphate internally despite a deficiency of TNSALP activity.
This article has been cited by other articles:
![]() |
R. A. Cahill, D. Wenkert, S. A. Perlman, A. Steele, S. P. Coburn, W. H. McAlister, S. Mumm, and M. P. Whyte Infantile Hypophosphatasia: Transplantation Therapy Trial Using Bone Fragments and Cultured Osteoblasts J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2923 - 2930. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Anderson, D. Harmey, N. P. Camacho, R. Garimella, J. B. Sipe, S. Tague, X. Bi, K. Johnson, R. Terkeltaub, and J. L. Millan Sustained Osteomalacia of Long Bones Despite Major Improvement in Other Hypophosphatasia-Related Mineral Deficits in Tissue Nonspecific Alkaline Phosphatase/Nucleotide Pyrophosphatase Phosphodiesterase 1 Double-Deficient Mice Am. J. Pathol., June 1, 2005; 166(6): 1711 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Harmey, L. Hessle, S. Narisawa, K. A. Johnson, R. Terkeltaub, and J. L. Millan Concerted Regulation of Inorganic Pyrophosphate and Osteopontin by Akp2, Enpp1, and Ank: An Integrated Model of the Pathogenesis of Mineralization Disorders Am. J. Pathol., April 1, 2004; 164(4): 1199 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Anderson, J. B. Sipe, L. Hessle, R. Dhamyamraju, E. Atti, N. P. Camacho, and J. L. Millan Impaired Calcification Around Matrix Vesicles of Growth Plate and Bone in Alkaline Phosphatase-Deficient Mice Am. J. Pathol., March 1, 2004; 164(3): 841 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Ballock and R. J. O'Keefe The Biology of the Growth Plate J. Bone Joint Surg. Am., March 31, 2003; 85(4): 715 - 726. [Full Text] [PDF] |
||||
![]() |
L. Hessle, K. A. Johnson, H. C. Anderson, S. Narisawa, A. Sali, J. W. Goding, R. Terkeltaub, and J. L. Millan Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization PNAS, July 9, 2002; 99(14): 9445 - 9449. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Terkeltaub Inorganic pyrophosphate generation and disposition in pathophysiology Am J Physiol Cell Physiol, July 1, 2001; 281(1): C1 - C11. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Johnson, L. Hessle, S. Vaingankar, C. Wennberg, S. Mauro, S. Narisawa, J. W. Goding, K. Sano, J. L. Millan, and R. Terkeltaub Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1 Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1365 - R1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cai, T. Michigami, T. Yamamoto, N. Yasui, K. Satomura, M. Yamagata, M. Shima, S. Nakajima, S. Mushiake, S. Okada, et al. Analysis of Localization of Mutated Tissue-Nonspecific Alkaline Phosphatase Proteins Associated with Neonatal Hypophosphatasia Using Green Fluorescent Protein Chimeras J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3936 - 3942. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |